Intrathecal baclofen therapy and multiple sclerosis: outcomes and patient satisfaction.

John R Vender, Mary Hughes, Betsy D. Hughes, Sydney Hester, Stephen Holsenback, Brenda Rosson

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

OBJECT: In this study the authors provide an assessment of intrathecal baclofen (ITB) therapy and evaluate patient outcomes and satisfaction. METHODS: Records for patients with multiple sclerosis who were selected as candidates for ITB therapy were reviewed for their response to test dose, surgical technique, surgery- and pump-related complications, and short- and long-term response to therapy. Family and caregiver assessments of the value of ITB therapy were also reviewed. CONCLUSIONS: Intrathecal baclofen therapy is safe and effective. Most patients and caregivers express satisfaction with the therapy and would recommend it to other patients. Spasm frequency appears to be the single most common variable positively affected by therapy.

Original languageEnglish (US)
JournalNeurosurgical Focus
Volume21
Issue number2
StatePublished - Jan 1 2006

Fingerprint

Baclofen
Patient Satisfaction
Multiple Sclerosis
Therapeutics
Caregivers
Spasm

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology

Cite this

Vender, J. R., Hughes, M., Hughes, B. D., Hester, S., Holsenback, S., & Rosson, B. (2006). Intrathecal baclofen therapy and multiple sclerosis: outcomes and patient satisfaction. Neurosurgical Focus, 21(2).

Intrathecal baclofen therapy and multiple sclerosis : outcomes and patient satisfaction. / Vender, John R; Hughes, Mary; Hughes, Betsy D.; Hester, Sydney; Holsenback, Stephen; Rosson, Brenda.

In: Neurosurgical Focus, Vol. 21, No. 2, 01.01.2006.

Research output: Contribution to journalArticle

Vender, JR, Hughes, M, Hughes, BD, Hester, S, Holsenback, S & Rosson, B 2006, 'Intrathecal baclofen therapy and multiple sclerosis: outcomes and patient satisfaction.', Neurosurgical Focus, vol. 21, no. 2.
Vender JR, Hughes M, Hughes BD, Hester S, Holsenback S, Rosson B. Intrathecal baclofen therapy and multiple sclerosis: outcomes and patient satisfaction. Neurosurgical Focus. 2006 Jan 1;21(2).
Vender, John R ; Hughes, Mary ; Hughes, Betsy D. ; Hester, Sydney ; Holsenback, Stephen ; Rosson, Brenda. / Intrathecal baclofen therapy and multiple sclerosis : outcomes and patient satisfaction. In: Neurosurgical Focus. 2006 ; Vol. 21, No. 2.
@article{4ffde6ce3293446c961539ffc085075b,
title = "Intrathecal baclofen therapy and multiple sclerosis: outcomes and patient satisfaction.",
abstract = "OBJECT: In this study the authors provide an assessment of intrathecal baclofen (ITB) therapy and evaluate patient outcomes and satisfaction. METHODS: Records for patients with multiple sclerosis who were selected as candidates for ITB therapy were reviewed for their response to test dose, surgical technique, surgery- and pump-related complications, and short- and long-term response to therapy. Family and caregiver assessments of the value of ITB therapy were also reviewed. CONCLUSIONS: Intrathecal baclofen therapy is safe and effective. Most patients and caregivers express satisfaction with the therapy and would recommend it to other patients. Spasm frequency appears to be the single most common variable positively affected by therapy.",
author = "Vender, {John R} and Mary Hughes and Hughes, {Betsy D.} and Sydney Hester and Stephen Holsenback and Brenda Rosson",
year = "2006",
month = "1",
day = "1",
language = "English (US)",
volume = "21",
journal = "Neurosurgical Focus",
issn = "1092-0684",
publisher = "American Association of Neurological Surgeons",
number = "2",

}

TY - JOUR

T1 - Intrathecal baclofen therapy and multiple sclerosis

T2 - outcomes and patient satisfaction.

AU - Vender, John R

AU - Hughes, Mary

AU - Hughes, Betsy D.

AU - Hester, Sydney

AU - Holsenback, Stephen

AU - Rosson, Brenda

PY - 2006/1/1

Y1 - 2006/1/1

N2 - OBJECT: In this study the authors provide an assessment of intrathecal baclofen (ITB) therapy and evaluate patient outcomes and satisfaction. METHODS: Records for patients with multiple sclerosis who were selected as candidates for ITB therapy were reviewed for their response to test dose, surgical technique, surgery- and pump-related complications, and short- and long-term response to therapy. Family and caregiver assessments of the value of ITB therapy were also reviewed. CONCLUSIONS: Intrathecal baclofen therapy is safe and effective. Most patients and caregivers express satisfaction with the therapy and would recommend it to other patients. Spasm frequency appears to be the single most common variable positively affected by therapy.

AB - OBJECT: In this study the authors provide an assessment of intrathecal baclofen (ITB) therapy and evaluate patient outcomes and satisfaction. METHODS: Records for patients with multiple sclerosis who were selected as candidates for ITB therapy were reviewed for their response to test dose, surgical technique, surgery- and pump-related complications, and short- and long-term response to therapy. Family and caregiver assessments of the value of ITB therapy were also reviewed. CONCLUSIONS: Intrathecal baclofen therapy is safe and effective. Most patients and caregivers express satisfaction with the therapy and would recommend it to other patients. Spasm frequency appears to be the single most common variable positively affected by therapy.

UR - http://www.scopus.com/inward/record.url?scp=33748434131&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748434131&partnerID=8YFLogxK

M3 - Article

C2 - 16918227

AN - SCOPUS:33748434131

VL - 21

JO - Neurosurgical Focus

JF - Neurosurgical Focus

SN - 1092-0684

IS - 2

ER -